Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01611337|
Recruitment Status : Completed
First Posted : June 4, 2012
Last Update Posted : September 19, 2017
Therapeutic alliance, and drug observance are major difficulties in the care of persons presenting schizophrenic symptomatology. They appear to be linked to insight, the consciousness that one has of his troubles. Nurse care in psychiatry aims at improving it, but usually without using specific evaluation tool. Insight is usually not evaluated during care, and its evolution is also not known, although it is highly probable that a positive evolution of insight for a person in hospital correlated to an adapted and optimal care by the medical and nursing teams. The investigators do not know examples of insight evaluation during a sequence of hospital care, or any evidence of insight variation in relation to evolution abilities of some schizophrenic patients cared in hospital.
The investigators propose here to evaluate insight in people presenting schizophrenia or related troubles, at the beginning of hospitalization (I1) and 1 month later (I2), to better characterize insight variations, and identify the sociodemographic, clinical and therapeutic variables linked to it.
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Other: insight variation measure||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||205 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry|
|Study Start Date :||June 2012|
|Actual Primary Completion Date :||July 2017|
|Actual Study Completion Date :||July 2017|
insight evaluation using the Q8 scale
Other: insight variation measure
insight variation between the firt week of hospitalization and 1 month later
- number of collected data explaining insight variation between the first week of hospitalization (I1) and 1 month later (I2) in a model of logistic regression [ Time Frame: first month after hospitalization ]identification of the variables explaining insight variation when it is ≥ 1,5: social and demographic data : age, gender, marital status, study level clinical : disease duration, Positive and Negative Syndrome Scale (PANSS), type of trouble therapeutic : care and treatments received during hospitalization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01611337
|Centre Hospitalier Esquirol|
|Limoges, France, 87000|
|Centre Hospitalier La Vallette|
|Saint-Vaury, France, 23320|
|Principal Investigator:||Danielle Bourlot, MD||Centre Hospitalier Esquirol|